HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine

Clinical Nephrology

Volumn 74, Issue 2, 2010, Pages 150-153

  Santoro, D ^a   Vita, G ^a   Vita, R ^a   Mallamace, A ^a   Savica, V ^a   Bellinghieri, G ^a   Benvenga, S ^a   Gangemi, S ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Autoimmunity; Haplotype; HBV vaccines; Lupus nephritis

Indexed keywords

HEPATITIS B VACCINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; FEMALE; HAPLOTYPE; HLA SYSTEM; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTOTOXICITY; POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ALLELE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUPUS NEPHRITIS;

ADULT; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VACCINES; HLA ANTIGENS; HUMANS; LUPUS NEPHRITIS; POLYMERASE CHAIN REACTION;

EID: 77955762608     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp74150     Document Type: Article

References (30)

1. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol. 2004; 16: 794-800. (Pubitemid 39423671)
2. Santoro D, Stella M, Montalto G, Castellino S. Lupus nephritis after hepatitis B vaccination: an uncommon complication. Clin Nephrol. 2007; 67: 61-63. (Pubitemid 46321747)
3. Houssiau FA, Vasconcelos C, D'Cruz D et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002; 46: 2121-2131.
4. Terasaki PI, Gjertson DW. HLA 1997. Los Angeles: Tissue Typing Laboratory; 1997.
5. Traherne JA. Human MH Carchitecture and evolution: implications for disease association studies. Int J Immunogenet. 2008; 35: 179-192. Epub 2008 Apr 8. Review.
6. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. Transpl Immunol. 2005; 14: 175-182. (Pubitemid 40848523)
7. Adamashvili I, Wolf R, Aultman D et al. Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus. Rheumatol Int. 2003; 23: 294-300. (Pubitemid 37518613)
8. Borradori L, Gueissaz F, Frenk E et al. Systemic lupus erythematosus associated with homozygous C2 deficiency. Apropos of a case report and literature review. Schweiz Med Wochenschr. 1991; 121: 418-423.
9. Gómez Campdera FJ, Yebra M, Vicario JL et al. Lupus nephropathy in childhood and familial lupus. Genetic study of a family. Med Clin (Barc). 1989; 92: 543-546.
10. Anaya JM, Delgado-Vega AM, Castiblanco J. Genetic basis of Sjögren's syndrome. How strong is the evidence? Clin Dev Immunol. 2006; 13: 209-222.
11. Loiseau P, Lepage V, Djelal F et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjögren syndrome. Hum Immunol. 2001; 62: 725-731. (Pubitemid 32634941)
12. Haas JP, Nevinny-Stickel C, Schoenwald U, Truckenbrodt H, Suschke J, Albert ED. Susceptible and protective major histocompatibility complex Class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol. 1994a; 41: 225-233.
13. Haas JP, Truckenbrodt H, Paul C, Hoza J, Scholz S, Albert ED. Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin Exp Rheumatol. 1994b; 12 (Suppl): 10.
14. Laivoranta-Nyman S. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis. 2004; 63: 1406-1412. (Pubitemid 39433943)
15. Maillefert JF, Sibilia J, Toussirot E et al. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999; 38: 978-983. (Pubitemid 29505080)
16. Choffray A, Pinquier L, Bachelez H. Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology. 2007; 215: 152-154. (Pubitemid 47230725)
17. Fineschi S. Can recombinant anti-hepatitis B vaccine be a cause of systemic lupus erythematosus? Lupus. 2001; 10: 830.
18. Guiserix J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron. 1996; 74: 441. (Pubitemid 26326729)
19. Tudela P, Martí S, Bonal J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 1992; 62: 236.
20. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity- "vaccinosis": a dangerous liaison? J Autoimmun. 2000; 14: 1-10.
21. Vial T, Descotes J. Autoimmune diseases and vaccinations. Eur J Dermatol. 2004; 14: 86-90.
22. Aprosin ZG, Serov VV, Lopatkina TN. The hepatitis Bvirus as a probable etiological factor in Sjögren's disease. Ter Arkh. 1993; 65: 73-78.
23. Toussirot E., Lohse A, Wendling D, Mougin C. Sjogren's syndrome occurring after hepatitis B vaccination. Arthritis Rheumatism. 2000; 43: 2139-2140.
24. Hachulla E, Houvenagel E, Mingui A, Vincent G, Laine A. Reactive arthritis after hepatitis B vaccination. J Rheumatol. 1990; 17: 1250-1251.
25. Hassan W, Oldham R. Reiter's syndrome and reactive arthritis in health care workers after vaccination. Br Med J. 1994; 309: 94. (Pubitemid 24216421)
26. Aherne P, Collins M. Psoriatic arthropathy. Ir Med J. 1995; 88: 72.
27. Geier DA, Geier MR. Acase-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005; 38: 295-301.
28. Older SA, Battafarano DF, Enzenauer RJ, Krieg AM. Can immunization precipitate connective tissue disease? Report of five cases of systemic lupus erythematosus and review of the literature. Semin Arthritis Rheum. 1999; 29: 131-139.
29. Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines-a review. Vaccine. 1998; 16: 329-334. (Pubitemid 28010766)
30. Maillefert JF, Tavernier C, Sibilia J, Vignon E. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by Battafarano et al and the letter by Senecal et al. Arthritis Rheum. 2000; 43: 468-469.